<DOC>
	<DOCNO>NCT01411254</DOCNO>
	<brief_summary>This study evaluate efficacy safety Betamethasone Microsphere ( DE-102 ) diabetic macular edema .</brief_summary>
	<brief_title>Efficacy Safety Betamethasone Microsphere Patients With Diabetic Macular Edema ( TSUBASA )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Provided sign , write informed consent 20 year age old diabetic macular edema Active proliferative diabetic retinopathy ( PDR ) study eye Uncontrolled diabetes mellitus hypertension Known steroidresponder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>DME</keyword>
</DOC>